This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Casodex

AstraZeneca PLC

Drug Names(s): Cosudex, bicalutamide

Description: Casodex (bicalutamide) is an oral non-steroidal anti-androgen for prostate cancer. Casodex competes with the androgens, dihydrotestosterone (DHT) and testosterone, for androgen receptor binding sites in the prostate cell. Since androgens normally regulate prostate cell growth and function, blockade of androgen action leads to apoptosis of hormone-sensitive cancer cells.


Casodex News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug